Trial Site Detail

 

Drug:
DCC-3116 + Ripretinib
Trial:
A Study of DCC-3116 in Combination with Anticancer Therapies in Participants with Advanced Malignancies
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

Hospital Ramon y Cajal

M-607, Km. 9, 100, Fuencarral-El Pardo     
Madrid , 28034
Spain

 

Principal Investigator:
 Maria Angeles Vaz Salgado, MD
Contact:
 Maria Angeles Vaz Salgado, MD +34 91 336 82 63 / 91 336 91 9 mavaz4@gmail.com
Activation Status of this Site:
 Active
Notes about this Site:
Hospital Ramon y Cajal Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.